ranibizumab
0 sources
ranibizumab
Summary
ranibizumab is a type of chemical entity[1]. ranibizumab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (41 views/month).[2]
Key Facts
- ranibizumab's instance of is recorded as type of chemical entity[3].
- ranibizumab's CAS Registry Number is recorded as 347396-82-1[4].
- ranibizumab's ATC code is recorded as S01LA04[5].
- ranibizumab's chemical formula is recorded as C₂₁₅₈H₃₂₈₂N₅₆₂O₆₈₁S₁₂[6].
- ranibizumab's subclass of is recorded as chemical compound[7].
- ranibizumab's has use is recorded as medication[8].
- ranibizumab's MeSH descriptor ID is recorded as D000069579[9].
- ranibizumab's has part is recorded as carbon[10].
- ranibizumab's ChEMBL ID is recorded as CHEMBL1201825[11].
- ranibizumab's Guide to Pharmacology Ligand ID is recorded as 6779[12].
- ranibizumab's route of administration is recorded as intravitreal administration[13].
- ranibizumab's Freebase ID is recorded as /m/0fv_4x[14].
- ranibizumab's UNII is recorded as ZL1R02VT79[15].
- ranibizumab's KEGG ID is recorded as D05697[16].
- ranibizumab's MeSH tree code is recorded as D12.776.124.486.485.114.224.060.868[17].
- ranibizumab's MeSH tree code is recorded as D12.776.124.790.651.114.224.060.868[18].
- ranibizumab's MeSH tree code is recorded as D12.776.377.715.548.114.224.200.868[19].
- ranibizumab's DrugBank ID is recorded as DB01270[20].
- ranibizumab's has characteristic is recorded as biopharmaceutical[21].
- ranibizumab's NDF-RT ID is recorded as N0000171789[22].
- ranibizumab's medical condition treated is recorded as diabetic retinopathy[23].
- ranibizumab's medical condition treated is recorded as retinal disease[24].
- ranibizumab's medical condition treated is recorded as Kuhnt-Junius degeneration[25].
- ranibizumab's medical condition treated is recorded as cystoid macular edema[26].
- ranibizumab's medical condition treated is recorded as retinal vein occlusion[27].
Why It Matters
ranibizumab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (41 views/month).[2] ranibizumab has Wikipedia articles in 14 language editions, a strong signal of global cultural recognition.[28] ranibizumab is known by 9 alternative names across languages and contexts.[29]